Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED's FIM Medical becomes the leading developer and distributor of European occupational healthcare devices with its purchase of Vistec GmbH

Vistec substantially boosts FIM Medical’s global revenue and makes it the largest medical device player in European occupational healthcare diagnostics.

ARCHIMED's FIM Medical becomes the leading developer and distributor of European occupational healthcare devices with its purchase of Vistec GmbH

ARCHIMED acquires generative AI Diagnostics player Arkstone to support fight against infectious disease

 August

 1, 

2025

ARCHIMED purchases BioVendor Group, a leading global player in advanced diagnostics

 March

 11, 

2025

ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders

 January

 27, 

2025

ARCHIMED finalizes the acquisition of IBA Lifesciences GmbH by Cube Biotech

 January

 13, 

2025

ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden

 November

 26, 

2024

ARCHIMED acquires SeqCenter, a fast-growing player in cutting-edge DNA and RNA gene sequencing

 November

 8, 

2024

< 1 2 3 4 … 16 >
368
  • ARCHIMED © 2025
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top